Tocilizumab Promotes Regulatory T-cell Alleviation in STAT3 Gain-of-function−associated Multi-organ Autoimmune Syndrome
Authors:
- 30 January 2017
- journal article
- case report
- Published by Elsevier in Clinical Therapeutics
- Vol. 39 (2) , 444-449
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Portal hypertension is associated with modulation of regulatory T cellsEuropean Journal of Inflammation, 2016
- Clinical implications of omics and systems medicine: focus on predictive and individualized treatmentJournal of Internal Medicine, 2015
- Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutationsBlood, 2015
- Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3Blood, 2015
- Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune diseaseNature Genetics, 2014
- Immune dysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) and IPEX-related disordersCurrent Opinion in Pediatrics, 2013
- Effect of interleukin-6 receptor blockade on the balance between regulatory T cells and T helper type 17 cells in rheumatoid arthritis patientsClinical and Experimental Immunology, 2013
- Hyperimmunoglobulin E syndrome and tyrosine kinase 2 deficiencyCurrent Opinion in Allergy and Clinical Immunology, 2007
- Early rheumatoid arthritis is associated with a deficit in the CD4+CD25high regulatory T cell population in peripheral bloodRheumatology, 2006
- Constitutive Activation of the Signal Transducer and Activator of Transcription Pathway in Celiac Disease LesionsThe American Journal of Pathology, 2003